October: Entered into a securities purchase agreement (SPA) with an institutional investor. Pursuant to the SPA, ReShape agreed to issue the investor a senior secured convertible note in the aggregate ...

IRVINE, Calif. and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic ...

LONDON, England—Anyone hoping that a third “tiebreaker” trial of the MitraClip against optimal medical therapy (OMT) would help clarify the role of transcatheter edge-to-edge repair (TEER) in heart ...

ReShape Lifesciences announces public offering of 1,054,604 shares at $2.50 each, aiming for $2.6 million in proceeds. ReShape Lifesciences announced the pricing of a public offering of 1,054,604 ...

In looking to 2026, the main trend in healthcare is how AI and connected systems will continue to transform all aspects of operations, including workforce management and supply chains. In a November ...

Backed by Y Combinator and Astanor Ventures, the latest investment will bring the company’s R&D and lab automation technology to researchers based in the US. Reshape Biotech, an AI and robotics ...

Imagine correcting your vision in under a minute – no lasers, blades or pain. Scientists have developed a novel, non-invasive technique that reshapes the cornea using only a mild electric current and ...

As new technologies reshape the world of work, artificial intelligence (AI) and automation are accelerating the digital transformation. These innovations are profoundly impacting how business leaders ...